​Dr. Colbath is a post-DVM fellow in the Department of Clinical Sciences who is studying the use of stem cells for cartilage repair and osteoarthritis in horses, in conjunction withe the laboratory of Dr. Laurie Goodrich. She is currently studying techniques for generating equine iPSC cells and then introducing these cells to become cartliage producing cells. She is also studying the immune modulary effects of mesenchymal stem cells in the equine joint.​

Dr. Dow is a Professor in the Department of Clinical Sciences at Colorado State University.  His lab investigates immune responses in infectious diseases, cancer and allergic and autoimmune diseases.  His lab is currently studying the immune modulatory effects of mesenchymal stem cells (MSC) and the use of MSC to treat chronic kidney disease, chronic liver disease, and chronic wound infections in dogs and cats.  More recently, the lab has also begun developing induced pluripotent stem cell lines (iPSC) from canines, felines, and equines for use in regenerative medicine studies. ​

​Dr. Duerr is an Assistant Professor in the Department of Clinical Sciences at Colorado State University. His group studies new approaches to treatment and rehabilitation of canine sports related injuries and chronic orthopedic conditions in dogs. He is also involved in ongoing investigations of new stem cell approaches to management of chronic osteoarthritis in dogs. ​

​Dr. Ehrhart is a Professor in the Animal Cancer Center in the Department of Clinical Sciences at Colorado State University.  Her laboratory investigates new approaches to improve bone healing for application to radiation therapy and bone cancer treatment.  Current projects include the use of local or systemic administration of mesenchymal stem cells to stimulate healing of allogeneic bone grafts following bone cancer surgery. ​

​Dr. Gonzales-Juarrero studies immunity to tuberculosis and the role of host immune defenses in the lungs. She also studies new lung drug delivey approaches to improve immunity to TB and to hasten lesion clearance in infected individuals.​

Dr. Goodrich is an Associate Professor in the Department of Clinical Sciences at Colorado State University.  Her laboratory studies new approaches to bone and joint healing in equine atheletes, including gene therapy and stem cell therapy.  Her lab is currently investigating the use of gene modified mesenchymal stem cells to suppress joint inflammation in joint disease in horses.​​

Dr. Guth is an Assistant Professor in the Department of Clinical Sciences  and Animal Cancer Center ​at Colorado State University.  She is currently investigating immunotherapeutic approaches to cancer treatment.  Among her projects is a studying investigating the use of cancer stem cell vaccines as a new approach to cancer immunotherapy.​

Dr. Kisiday is an Associate Professor in the Department of Clinical Sciences at Colorado State University.  His laboratory studies factors that regulate the maturation of mesenchymal stem cells into functional cartilage and bone tissues.  His studies investigate the influence of substrates and specific growth factors on the mechanical properties of the regenerating mesenchymal stem cells.​

​Dr. Koch is a Professor in the Department of Dermatology at the University of Colorado Denver and the Gates Center for Regenerative Medicine and Stem Cell Biology.  His laboratory focuses on understanding the genetic basis of inherited skin disorders in humans.  The Koch group also uses iPSC technology to investigate new genetic approaches to reversing the defects in genetic skin disorders. 

​Dr. Lappin is a Professor in the Department of Clinical Sciences at Colorado State University.  His laboratory studies immune responses to vaccination against respiratory viruses in cats, as well as immune responses to feline vaccines.  He also oversees a large diagnostic service for feline infectious diseases, including toxoplasmosis, Bartonella, Ehrlichia, and other infectious agents of cats.​

Dr. Orton is a Professor in the Department of Clinical Sciences and the Director of the Animal Heart Center at Colorado State University.  His group studies the pathogenesis of valvular heart disease in dogs and humans.  His laboratory also uses new approaches to inhibit immune responses against xenogeneic heart valves.​

​Dr. Regan is an Assistant Professor in the Department of Microbiology, Immunology, and Pathology and the Animal Cancer Center. He is currently investigating monocyte targeted therapeutics for enhancing cancer vaccine effectiveness and suppressing the growth of tumor metastases, using both mouse models and clinical studies in dogs with cancer.​​

Dr. Webb is a Research Scientist in the Department of Clinical Sciences.  She investigates the use of mesenchymal stem cells for suppressing airway inflammation in mouse asthma models.  In addition, she investigates the mechanisms by which mesenchymal stem cells suppress T cell responses in mice and cats.​

​Dr. Wheat investigates the role of dendritic cells in the host immune response to vector-borne pathogens. He also studies the impact of mesenchymal stem cells on DC function, and the role of DC in host immunity to inhaled pathogens and immunotherapies.​​​

Dr. Zabel is a Professor in the Department of Microbiology, Immunology, and Pathology at Colorado State University.  His laboratory investigates the immune pathogenesis of prion diseases, specifically chronic wasting disease, and how complement proteins and white blood cells facilitate the spread of the organism.  In addition, his laboratory investigates novel immune therapeutic approaches to controlling prion infection in the brain, using mouse models of infection.​​